Jia Li

Jia Li

Auto-generated profile, based on publicly available information

Jia Li

Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JLJia Li
Jia Li
SZSibo Zhao
Sibo Zhao
MLMinjung Lee
Minjung Lee
YYYue Yin
Yue Yin
JLJin Li
Jin Li
DSdeqiang sun
deqiang sun
A reliable pipeline to identify DNA methylation signatures in CSF ctDNA could serve as potential biomarkers for MB patients.

18 August 2023 in Experimental Hematology
Verified
Journal Article
Closed access
LGLei Guo
Lei Guo
JLJia Li
Jia Li
THtingting Hong
tingting Hong
YLYi-Tsang Lee
Yi-Tsang Lee
YZYubin Zhou
Yubin Zhou
YHYun Huang
Yun Huang

31 March 2023
Verified
Other
Open access
MLMinjung Lee
Minjung Lee
JLJianfang Li
Jianfang Li
JLJia Li
Jia Li
SFShaohai Fang
Shaohai Fang
JZJoanna Zhang
Joanna Zhang
YHYun Huang
Yun Huang
Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression. Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments. In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment. Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features. Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation. Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T-cell function following Tet2 depletion. Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.Significance:This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.